ATE76974T1 - Verfahren zur diagnose von infektionen, bei welchem lipopolyscaccharidantigene bestimmt werden. - Google Patents

Verfahren zur diagnose von infektionen, bei welchem lipopolyscaccharidantigene bestimmt werden.

Info

Publication number
ATE76974T1
ATE76974T1 AT88905974T AT88905974T ATE76974T1 AT E76974 T1 ATE76974 T1 AT E76974T1 AT 88905974 T AT88905974 T AT 88905974T AT 88905974 T AT88905974 T AT 88905974T AT E76974 T1 ATE76974 T1 AT E76974T1
Authority
AT
Austria
Prior art keywords
support
antigen
antigens
membrane
solution
Prior art date
Application number
AT88905974T
Other languages
English (en)
Inventor
Shirley Jean Richmond
Christopher Charles Storey
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878716489A external-priority patent/GB8716489D0/en
Priority claimed from GB888812802A external-priority patent/GB8812802D0/en
Application filed by Univ Manchester filed Critical Univ Manchester
Application granted granted Critical
Publication of ATE76974T1 publication Critical patent/ATE76974T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56927—Chlamydia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT88905974T 1987-07-14 1988-07-12 Verfahren zur diagnose von infektionen, bei welchem lipopolyscaccharidantigene bestimmt werden. ATE76974T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB878716489A GB8716489D0 (en) 1987-07-14 1987-07-14 Diagnostic method
GB888812802A GB8812802D0 (en) 1988-05-28 1988-05-28 Diagnostic method
EP88905974A EP0371049B1 (de) 1987-07-14 1988-07-12 Verfahren zur diagnose von infektionen, bei welchem lipopolyscaccharidantigene bestimmt werden
PCT/GB1988/000561 WO1989000695A1 (en) 1987-07-14 1988-07-12 Method for the diagnosis of infections with detection of lipopolysaccharide antigens

Publications (1)

Publication Number Publication Date
ATE76974T1 true ATE76974T1 (de) 1992-06-15

Family

ID=26292486

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88905974T ATE76974T1 (de) 1987-07-14 1988-07-12 Verfahren zur diagnose von infektionen, bei welchem lipopolyscaccharidantigene bestimmt werden.

Country Status (6)

Country Link
EP (1) EP0371049B1 (de)
JP (1) JPH03500682A (de)
AT (1) ATE76974T1 (de)
AU (1) AU616673B2 (de)
DE (1) DE3871799D1 (de)
WO (1) WO1989000695A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122449A (en) * 1988-10-07 1992-06-16 Eastman Kodak Company Use of a protease in the extraction of chlamydial, gonococcal and herpes antigens
US5047326A (en) * 1988-10-07 1991-09-10 Eastman Kodak Company Immunmological reagent composition and its use in the determination of chlamydial or gonococcal antigens
US5089389A (en) * 1989-08-25 1992-02-18 Eastman Kodak Company Buffered composition, coated article test device and a method for their use
US5187066A (en) * 1990-02-14 1993-02-16 Syntex (U.S.A.) Inc. Methods for detecting amphiphilic antigens
US5399484A (en) * 1991-10-08 1995-03-21 Eastman Kodak Company Use of blocking protein with high pH extraction in method to determine a microorganism associated with periodontal disease and kit useful therefor
US5741697A (en) * 1995-11-30 1998-04-21 University Of Rochester Bacteriophage of chlamydia psittaci
DE19756782A1 (de) 1997-12-19 1999-06-24 Dade Behring Marburg Gmbh Nachweis und Bestimmung festphasenassoziierter Faktoren

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES521371A0 (es) * 1982-04-12 1984-05-16 Hybritech Inc Un procedimiento para la purificacion de un anticuerpo.
US4497899A (en) * 1982-04-12 1985-02-05 Abbott Laboratories Immunoassay for Chlamydia trachomatis antigens
WO1985002685A1 (en) * 1983-12-12 1985-06-20 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
AU5259786A (en) * 1985-01-30 1986-08-07 United States Of America, The Monoclonal antibodies against chlamydial genes specific lipopolysaccharide
FI860249A (fi) * 1985-02-28 1986-08-29 Becton Dickinson Co Apparat och foerfarande foer flerfaldigt, samtidigt prov.
EP0264036B1 (de) * 1986-10-16 1993-06-30 Abbott Laboratories Analytisches Gerät und Verfahren zum Nachweis von Chlamydia Trachomatis und Neisseria Gonorrhoeae

Also Published As

Publication number Publication date
JPH03500682A (ja) 1991-02-14
AU616673B2 (en) 1991-11-07
DE3871799D1 (de) 1992-07-09
AU1994788A (en) 1989-02-13
WO1989000695A1 (en) 1989-01-26
EP0371049A1 (de) 1990-06-06
EP0371049B1 (de) 1992-06-03

Similar Documents

Publication Publication Date Title
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
DE3689941D1 (de) Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.
ES2009939A6 (es) Un inmunoensayo para la deteccion simultanea de antigenos yno anticuerpos en una muestra a ensayar de un fluido fisiologico.
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
ATE141286T1 (de) Hiv-peptide, künstliche hiv-antigene und immuntestsätze
RU94046284A (ru) Способ обнаружения антител, способ с-крекинга компонентов крови, набор для обнаружения антител к hcv
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
JPH04297871A (ja) クラミジア・トラコマティス抗体測定方法及びクラミジア・トラコマティス感染症診断用製剤
ATE76974T1 (de) Verfahren zur diagnose von infektionen, bei welchem lipopolyscaccharidantigene bestimmt werden.
SE8701905L (sv) Foerfarande och kit foer diagnos av iga-nefropati
DE3280319D1 (de) Fuer endotoxine spezifische antikoerper.
Cohen et al. Antibodies against Staphylococcus aureus in nonimmunized rabbits
ATE74211T1 (de) Verfahren zum nachweis eines analyten sowie hierfuer geeignetes mittel.
ES2141348T3 (es) Metodo de deteccion de la presencia de una especie de mycobacterium, kit y anticuerpos utilizados en este metodo.
Nassau et al. Detection of antibodies to Mycobacterium tuberculosis by solid phase radioimmunoassay
ATE316245T1 (de) Synthetische antigene zum nachweis von syphilis
KR880014376A (ko) Hiv 특이 항원 영역의 모노클로날 항체 및 그 용법
EP0402993A3 (de) Diagnostischer Testsatz und Verfahren zum Nachweis des Chlamydia-Antigens unter Verwendung einer Membran mit Hydroxylgruppen an der Oberfläche
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
JPH04231872A (ja) 免疫反応性リガンドを測定するための試験キットおよび測定方法
DE3686717T2 (de) Immuntestverfahren.
JPH02210263A (ja) 微孔質膜を使用するクラミジア抗原または淋菌抗原の測定方法および診断試験キット
LaBrec et al. Serological identification of Shigella flexneri by means of fluorescent antibody
Zhou et al. The rapid determination of the ABO group from body fluids (or stains) by dot enzyme-linked immunosorbent assay (Dot-ELISA) using enzyme-labeled monoclonal antibodies
DE69227623T2 (de) Verfahren zum Nachweis einer CMV-Infektion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties